Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists
Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists
复制标题
DOI:
10.1016/s0091-3057(02)00748-7
复制
发表时间:
2002-06-01
影响因子:
3.6
通讯作者:
Nowrouzi, M
中科院分区:
文献类型:
--
作者:
Farzin, D;Asghari, L;Nowrouzi, M
The effects of different histamine receptor agonists and antagonists on the nociceptive threshold were investigated in mice by two different kinds of noxious stimuli: thermal (hot plate) and chemical (acetic acid-induced abdominal writhing). Intracerebroventricular (icv) injection of the histamine H, receptor agonist, HTMT (6-[2-(4-imidazolyl)ethylamino]-N-(4-trifluoromethylphenyl) heptanecarboxamide) (50 mug/mouse), produced a hypernociception in the hot plate and writhing tests. Conversely, intraperitoneal (ip) injection of dexchlorpheniramine (30 and 40 mg/kg) and diphenhydramine (20 and 40 mg/kg) increased the pain threshold in both tests. The histamine H-2 receptor agonist, dimaprit (50 and 100 mug/mouse icv), or antagonist, ranitidine (50 and 100 l.Lg/mouse icv), raised the pain threshold in both hot plate and writhing tests. In the mouse hot plate test, the histamine H-3 receptor agonist, imetit (50 mg/kg ip), reduced the pain threshold, while the histamine H-3 receptor antagonist, thioperamide (10 and 20 mg/kg ip), produced an antinociception. The hypernociceptive effects of HTMT and imetit were antagonized by dexchlorpheniramine (20 mg/kg ip) and thioperamide (5 mg/kg ip), respectively. The results suggest that histaminergic mechanisms may be involved in the modulation of nociceptive stimuli. (C) 2002 Elsevier Science Inc. All rights reserved.